Form 8-K Cornerstone Building For: Apr 22
http://archive.fast-edgar.com/20240423/A422L222Z22PP2P2222222Y2PQQ7CZ22A262
Filed on: April 23, 2024
Form 8-K General Motors Co For: Apr 23
0001467858FALSE00014678582024-04-232024-04-23UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549___________________FORM 8-K ___________________CURRENT REPORTPursuant to Section 13 or 15(d) ofthe Securities Exchange Act of 1934Date of Report (Date of earliest event reported): April 23, 2024 ___________________GENERAL MOTORS COMPANY (Exact name of registrant as specified in its charter)__________________Delaware001-3496027-0756180(State or other... (continue reading...)
Form DEFA14A Desktop Metal, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Dime Community Bancshare For: Apr 23
-
Form 8-K FISERV INC For: Apr 23
-
Form ARS Syros Pharmaceuticals, For: Dec 31
-
Form ARS Cabaletta Bio, Inc. For: Dec 31
-
Form 6-K ONECONNECT FINANCIAL For: Apr 23
-
Form 8-K HALLIBURTON CO For: Apr 23
-
Form D VIVIFI MEDICAL SPV 2023
-
Form 6-K ONECONNECT FINANCIAL For: Apr 23
-
Form 8-K SHERWIN WILLIAMS CO For: Apr 23
-
Form 6-K ProQR Therapeutics N.V. For: Apr 23
-
Form DEFA14A Syros Pharmaceuticals,
-
Form DEFA14A Cabaletta Bio, Inc.
-
Form 8-K KIMBERLY CLARK CORP For: Apr 23
-
Form 8-K Philip Morris Internatio For: Apr 23
-
Form 6-K Mobilicom Ltd For: Apr 23
-
Form DEF 14A Syros Pharmaceuticals, For: Jun 05
-
Form DSTRBRPT International Finance
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form DSTRBRPT International Finance
-
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
-
Form DSTRBRPT International Finance
-
Form 8-K Seres Therapeutics, Inc. For: Apr 19
-
Form 10-Q MANHATTAN BRIDGE CAPITAL For: Mar 31
-
Form 8-K ClearSign Technologies For: Apr 22
-
Form 8-K Theriva Biologics, Inc. For: Apr 23
-
Form 10-Q MBC FUNDING II CORP. For: Mar 31
-
Form 6-K Tiziana Life Sciences For: Apr 23
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form 8-K Option Care Health, Inc. For: Apr 23
-
Form 8-K RTX Corp For: Apr 23
-
Form 10-Q BANK OF HAWAII CORP For: Mar 31
-
Form 8-K PENTAIR plc For: Apr 23
-
Form 8-K RYDER SYSTEM INC For: Apr 23
-
Form 8-K MSCI Inc. For: Apr 23
-
Form 1-K Red Oak Capital Fund For: Dec 31
-
Form 8-K QUEST DIAGNOSTICS INC For: Apr 23
-
Form D Emma Grace Healing Hospi
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 8-K XEROX CORP For: Apr 23 Filed by: Xerox Holdings Corp
-
Form ARS UNIVERSAL HEALTH REALTY For: Dec 31
-
Form 8-K CARDINAL HEALTH INC For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form DEFA14A UNIVERSAL HEALTH REALTY
-
Form 8-K Aquaron Acquisition Corp For: Apr 19
-
Form 20-F ONECONNECT FINANCIAL For: Dec 31
-
Form D Palumni-SM-0404 Fund I,
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Ermenegildo Zegna N.V. For: Apr 23
-
Form 10-Q HERC HOLDINGS INC For: Mar 31
-
Form 1-K Future Cardia, Inc. For: Dec 31